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Introduction {#jah31711-sec-0005}
============

Use of intravascular ultrasound (IVUS) for stent optimization during chronic total occlusion percutaneous coronary intervention (CTO PCI) has been shown to improve long‐term outcomes,[1](#jah31711-bib-0001){ref-type="ref"}, [2](#jah31711-bib-0002){ref-type="ref"}, [3](#jah31711-bib-0003){ref-type="ref"} yet its impact on crossing has received limited study.[1](#jah31711-bib-0001){ref-type="ref"}, [2](#jah31711-bib-0002){ref-type="ref"}, [3](#jah31711-bib-0003){ref-type="ref"}, [4](#jah31711-bib-0004){ref-type="ref"}, [5](#jah31711-bib-0005){ref-type="ref"}, [6](#jah31711-bib-0006){ref-type="ref"}, [7](#jah31711-bib-0007){ref-type="ref"}, [8](#jah31711-bib-0008){ref-type="ref"}, [9](#jah31711-bib-0009){ref-type="ref"} Intravascular imaging can help resolve proximal cap ambiguity by identifying the position of the main branch[10](#jah31711-bib-0010){ref-type="ref"} and clarifying guidewire position during both antegrade and retrograde CTO crossing attempts.[11](#jah31711-bib-0011){ref-type="ref"} IVUS can determine optimal balloon sizing for the reverse controlled antegrade and retrograde tracking and dissection (reverse CART) technique.[11](#jah31711-bib-0011){ref-type="ref"}, [12](#jah31711-bib-0012){ref-type="ref"} Moreover, intravascular imaging can facilitate sizing of balloons and stents and optimize stent expansion and stent strut apposition.[13](#jah31711-bib-0013){ref-type="ref"} We examined a large multicenter contemporary CTO PCI registry to determine the frequency of intravascular imaging use during CTO PCI and the associated procedural outcomes.

Methods {#jah31711-sec-0006}
=======

Patient Population {#jah31711-sec-0007}
------------------

We analyzed the frequency of use and outcomes of intravascular imaging among 619 chronic CTO PCIs performed between 2012 and 2015 at 7 US centers: Appleton Cardiology, Appleton Wisconsin; Henry Ford Hospital, Detroit, Michigan; Massachusetts General Hospital, Boston, Massachusetts; Medical Center of the Rockies, Loveland, Colorado; St. Luke\'s Health System\'s Mid‐America Heart Institute, Kansas City, Missouri; VA North Texas Health Care System, Dallas, Texas; and VA San Diego Healthcare System, San Diego, California.

Enrollment was performed during only part of the study period in some centers due to participation in other studies. Data collection was performed both prospectively and retrospectively and was recorded in a dedicated online database (PROGRESS CTO: Prospective Global Registry for the Study of Chronic Total Occlusion Intervention, [Clinicaltrials.gov](http://Clinicaltrials.gov) Identifier: NCT02061436).[14](#jah31711-bib-0014){ref-type="ref"}, [15](#jah31711-bib-0015){ref-type="ref"}, [16](#jah31711-bib-0016){ref-type="ref"}, [17](#jah31711-bib-0017){ref-type="ref"}, [18](#jah31711-bib-0018){ref-type="ref"}, [19](#jah31711-bib-0019){ref-type="ref"}, [20](#jah31711-bib-0020){ref-type="ref"}, [21](#jah31711-bib-0021){ref-type="ref"}, [22](#jah31711-bib-0022){ref-type="ref"}, [23](#jah31711-bib-0023){ref-type="ref"}, [24](#jah31711-bib-0024){ref-type="ref"} The study was approved by the institutional review board of each site and a waiver of informed consent was obtained.

Definitions {#jah31711-sec-0008}
-----------

Coronary CTOs were defined as coronary lesions with Thrombolysis In Myocardial Infarction grade 0 flow of at least 3‐month duration.[25](#jah31711-bib-0025){ref-type="ref"} Estimation of the occlusion duration was based on first onset of anginal symptoms, prior history of myocardial infarction in the target vessel territory, or comparison with a prior angiogram. Calcification was assessed by angiography as mild (spots), moderate (involving ≤50% of the reference lesion diameter), and severe (involving \>50% of the reference lesion diameter). Moderate proximal vessel tortuosity was defined as the presence of at least 2 bends \>70° or 1 bend \>90° and severe tortuosity as 2 bends \>90° or 1 bend \>120° in the CTO vessel. The Japanese Chronic Total Occlusion score was calculated as described by Morino et al.[26](#jah31711-bib-0026){ref-type="ref"} The Progress CTO score was calculated as described by Christopoulos et al.[22](#jah31711-bib-0022){ref-type="ref"} Technical success was defined as successful CTO revascularization with achievement of \<30% residual diameter stenosis within the treated segment and restoration of Thrombolysis In Myocardial Infarction grade 3 antegrade flow. Procedural success was defined as achievement of technical success with no in‐hospital major adverse cardiac events (MACE). In‐hospital MACE included any of the following adverse events prior to hospital discharge: death, myocardial infarction, urgent repeat target vessel revascularization with either PCI or coronary artery bypass graft surgery, tamponade requiring either pericardiocentesis or surgery, and stroke. Myocardial infarction was defined using the Third Universal Definition of Myocardial Infarction.[27](#jah31711-bib-0027){ref-type="ref"}

Statistical Analysis {#jah31711-sec-0009}
--------------------

The primary comparison of the study was between procedures in which intravascular imaging (IVUS and/or optical coherence tomography \[OCT\]) was used versus those in which it was not used for crossing the occlusion (Figure [1](#jah31711-fig-0001){ref-type="fig"}). In a secondary analysis of cases that were successfully crossed with a guidewire, a comparison was made between use versus no use of intravascular imaging for stent sizing/optimization.

![Flow chart of the study. CTO indicates chronic total occlusion; PCI, percutaneous coronary intervention.](JAH3-5-e003890-g001){#jah31711-fig-0001}

Continuous variables were presented as mean±SD or median (interquartile range) and were compared using the *t* test, or Wilcoxon rank‐sum test, as appropriate. Categorical data were reported as frequencies or percentages and compared using the χ^2^ test or Fisher\'s exact test, as appropriate. The baseline clinical characteristics and the procedural outcomes were analyzed among the patients (606 patients), while the angiographic characteristics were analyzed among procedures (619 procedures). All statistical analyses were performed with JMP 11.0 (SAS Institute, Cary, NC). Two‐sided *P*\<0.05 were considered statistically significant.

Results {#jah31711-sec-0010}
=======

Baseline Patient and Procedural Characteristics {#jah31711-sec-0011}
-----------------------------------------------

A total of 619 CTO PCI procedures performed in 606 patients were included in the present analysis. The baseline patient and angiographic characteristics of the study population are summarized in Table [1](#jah31711-tbl-0001){ref-type="table-wrap"}. Mean age was 65.4±10 years and 85% of the patients were men with high prevalence of diabetes (50%), dyslipidemia (92%), and hypertension (88%). Approximately one third had congestive heart failure (33%) or prior coronary artery bypass graft surgery (32%).

###### 

Baseline Clinical Characteristics of the Study Patients, Classified According to Whether Intravascular Imaging Was Used to Guide CTO Crossing or Not

  Variable                                                            Overall          Imaging for Crossing   No Imaging or Imaging for Stent Optimization   *P‐*Value
  ------------------------------------------------------------------- ---------------- ---------------------- ---------------------------------------------- -----------
  Age, y[a](#jah31711-note-0002){ref-type="fn"}                       65.4±10          65±10                  66±10                                          0.466
  Men                                                                 85%              91%                    84%                                            0.066
  BMI, kg/m^2^ [a](#jah31711-note-0002){ref-type="fn"}                30.6±6           31.7±7                 30.4±6                                         0.058
  Diabetes mellitus                                                   50%              58%                    49%                                            0.069
  Hypertension                                                        88%              88%                    88%                                            0.908
  Dyslipidemia                                                        92%              94%                    92%                                            0.631
  Smoking (current)                                                   23%              77%                    77%                                            0.908
  LVEF (%)[a](#jah31711-note-0002){ref-type="fn"}                     51±15            48±15                  51±15                                          0.056
  Family history of CAD                                               24%              24%                    24%                                            0.897
  Congestive heart failure                                            33%              37%                    32%                                            0.29
  Prior myocardial infarction                                         45%              46%                    44%                                            0.793
  Prior CABG                                                          32%              41%                    30%                                            0.024
  Prior CVD                                                           11%              8%                     12%                                            0.331
  Prior PVD                                                           15%              12%                    15%                                            0.403
  Baseline creatinine, mg/dL[b](#jah31711-note-0003){ref-type="fn"}   1.0 (0.8, 1.2)   1.0 (0.9, 1.3)         1.0 (0.8, 1.2)                                 0.615

Imaging for crossing: cases in which intravascular imaging was used for crossing the chronic total occlusion. No imaging or imaging for stent optimization: cases in which intravascular imaging was not used or cases in which intravascular imaging was used for stent optimization. BMI indicates body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; CTO, chronic total occlusion; CVD, cerebrovascular disease; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; PVD, peripheral vascular disease.

Mean±SD.

Median (interquartile range).

Intravascular imaging was used in 38% of the procedures, as follows: IVUS in 36%, OCT in 3%, and both in 1.45%. The indications for intravascular imaging were to facilitate CTO crossing (overall 35.7%, antegrade in 27.9%, and retrograde in 7.8%) and stent sizing (26.3%) or optimization (38.0%) (Figure [2](#jah31711-fig-0002){ref-type="fig"}). Wide variability was observed in the frequency of intravascular imaging use among various centers (0--58%, Figure [3](#jah31711-fig-0003){ref-type="fig"}).

![Use of intravascular imaging during chronic total occlusion percutaneous coronary intervention. CART indicates controlled antegrade and retrograde tracking and dissection.](JAH3-5-e003890-g002){#jah31711-fig-0002}

![Frequency of intravascular imaging use at the study participating centers. The absolute number of the cases with intravascular imaging use is listed in parentheses.](JAH3-5-e003890-g003){#jah31711-fig-0003}

Intravascular Imaging for Crossing {#jah31711-sec-0012}
----------------------------------

The baseline clinical and angiographic characteristics of patients who did and those who did not undergo intravascular imaging for crossing were similar (Tables [1](#jah31711-tbl-0001){ref-type="table-wrap"} and [2](#jah31711-tbl-0002){ref-type="table-wrap"}). The most common CTO PCI target vessel was the right coronary artery (52%), followed by the left anterior descending artery (26%), and the left circumflex (22%). Moderate to severe calcification and moderate to severe tortuosity were present in 53% and 42%, respectively. Procedural outcomes are summarized in Table [3](#jah31711-tbl-0003){ref-type="table-wrap"}. Overall technical and procedural rates were 90.1% and 88.6%, respectively. Antegrade wiring was the successful crossing strategy in 48% of the cases, antegrade dissection and re‐entry in 23%, and the retrograde approach in 23%.

###### 

Angiographic Characteristics Classified According to Whether Intravascular Imaging was Used to Guide CTO Crossing or Not

  Variable                                                      Overall          Imaging for Crossing   No Imaging or Imaging for Stent Optimization   *P‐*Value
  ------------------------------------------------------------- ---------------- ---------------------- ---------------------------------------------- -----------
  CTO target vessel                                                                                                                                    0.861
  RCA                                                           52%              51%                    52%                                            
  LAD                                                           26%              28%                    26%                                            
  LCX                                                           22%              21%                    22%                                            
  Successful crossing strategy                                                                                                                         \<0.0001
  Antegrade wiring                                              48%              23%                    53%                                            
  Retrograde                                                    23%              47%                    17%                                            
  Antegrade dissection and re‐entry                             23%              25%                    23%                                            
  None                                                          6%               5%                     7%                                             
  First crossing strategy                                                                                                                              0.889
  Antegrade wiring                                              78%              78%                    78%                                            
  Retrograde                                                    14%              15%                    14%                                            
  Antegrade dissection and re‐entry                             8%               6%                     8%                                             
  Retrograde crossing attempt                                   37%              67%                    31%                                            \<0.0001
  J‐CTO score[a](#jah31711-note-0005){ref-type="fn"}            2.51±1.20        2.86±1.19              2.43±1.19                                      0.001
  P‐CTO score[a](#jah31711-note-0005){ref-type="fn"}            1.37±1.01        1.64±1.00              1.18±1.02                                      \<0.0001
  Calcification (moderate/severe)                               53%              60%                    51%                                            0.103
  Tortuosity (moderate/severe)                                  42%              48%                    40%                                            0.126
  Proximal cap ambiguity                                        31%              49%                    26%                                            \<0.0001
  In‐stent restenosis                                           17%              20%                    16%                                            0.334
  Prior failure to open CTO                                     16%              21%                    15%                                            0.147
  Interventional collaterals                                    53%              52%                    53%                                            0.794
  Side branch at the proximal cap                               50%              61%                    47%                                            0.009
  Blunt/no stump, %                                             57%              68%                    55%                                            0.009
  Vessel diameter, mm[b](#jah31711-note-0006){ref-type="fn"}    2.6 (2.5, 3.0)   2.5 (2.5, 3.0)         2.7 (2.5, 3.0)                                 0.684
  Occlusion length, mm[b](#jah31711-note-0006){ref-type="fn"}   30 (19, 45)      30 (22, 50)            30 (18, 40)                                    0.093
  Number of stents used                                         2.53±1.2         2.78±1.4               2.48±1.19                                      0.047

Imaging for crossing: cases in which intravascular imaging was used for crossing the chronic total occlusion. No imaging or imaging for stent optimization: cases in which intravascular imaging was not used or cases in which intravascular imaging was used for stent optimization. CTO indicates chronic total occlusion; J‐CTO score, Japanese chronic total occlusion score; LAD, left anterior descending artery; LCX, left circumflex artery; P‐CTO score, Progress chronic total occlusion score; RCA, right coronary artery.

Mean±SD.

Median (interquartile range).

###### 

Procedural Outcomes of the Study Patients, Classified According to Whether Intravascular Imaging was Used to Guide CTO Crossing or Not

  Variable                                                                 Overall             Imaging for Crossing   No Imaging or Imaging for Stent Optimization   *P‐*Value
  ------------------------------------------------------------------------ ------------------- ---------------------- ---------------------------------------------- -----------
  Technical success                                                        90.1%               92.8%                  89.6%                                          0.302
  Procedural success                                                       88.6%               90.1%                  88.3%                                          0.588
  Procedural time, minute[a](#jah31711-note-0008){ref-type="fn"}           142 (96, 210)       192 (130, 255)         131 (90, 192)                                  \<0.0001
  Fluoroscopy time, minute[a](#jah31711-note-0008){ref-type="fn"}          45 (27, 75)         71 (44, 93)            39 (25, 69)                                    \<0.0001
  Air kerma radiation dose (Gray)[a](#jah31711-note-0008){ref-type="fn"}   3.59 (2.27, 5.40)   4.98 (3.11, 6.04)      3.42 (2.09, 5.09)                              \<0.0001
  Contrast volume[a](#jah31711-note-0008){ref-type="fn"}                   280 (205, 367)      310 (240, 400)         270 (200, 360)                                 0.004
  MACE                                                                     3.1%                2.7%                   3.2%                                           0.772
  Death                                                                    0.5%                0.0%                   0.6%                                           0.411
  Acute Q wave MI                                                          0%                  0%                     0.0%                                           ---
  Acute MI                                                                 1.3%                1.8%                   1.2%                                           0.623
  Re‐PCI                                                                   0.3%                0.0%                   0.4%                                           0.502
  Stroke                                                                   0.4%                0.0%                   0.6%                                           0.411
  Emergency CABG                                                           0%                  0%                     0.0%                                           ---
  Pericardiocentesis                                                       0.9%                0.9%                   1.0%                                           0.916

Imaging for crossing: cases in which intravascular imaging was used for crossing the chronic total occlusion; No imaging or imaging for stent optimization: cases in which intravascular imaging was not used or cases in which intravascular imaging was used for stent optimization. CABG indicates coronary artery bypass grafting; CTO, chronic total occlusion; MACE, major adverse cardiac events; MI, myocardial infarction; PCI, percutaneous coronary intervention.

Median (interquartile range).

Intravascular imaging for crossing was used more commonly in lesions with proximal cap ambiguity (49% versus 26%, *P*\<0.0001), side branch at the proximal cap (61% versus 47%, *P*=0.035), longer occlusion length (30 mm \[interquartile range: 22, 50\] versus 28 mm \[15, 44\], *P*=0.009), and higher Japanese Chronic Total Occlusion (2.86±1.19 versus 2.43±1.19, *P*=0.001) and Progress CTO (1.64±1.00 versus 1.18±1.02, *P*\<0.0001) score. Cases in which intravascular imaging was used for crossing were more likely to succeed using the retrograde approach or antegrade dissection and reentry (47% versus 17% and 25% versus 23%), as compared with antegrade wiring (23% versus 53%, *P*\<0.0001).

Procedural outcomes are summarized in Table [3](#jah31711-tbl-0003){ref-type="table-wrap"} and Figure [4](#jah31711-fig-0004){ref-type="fig"}. Technical and procedural success were similar in cases in which intravascular imaging was used for crossing (92.8% versus 89.6%, *P*=0.302 and 90.1% versus 88.3%, *P*=0.588, respectively), whereas the incidence of MACE was similarly low in both groups (2.7% versus 3.2%, *P*=0.772). Success and complication rates were similar among centers with high versus low intravascular imaging use (data not shown). There was no significant difference in the incidence of death, myocardial infarction, repeated PCI, stroke, and pericardiocentesis. Mean procedure duration was significantly longer among procedures in which intravascular imaging was used for crossing (192 minutes \[130, 255\] versus 131 minutes \[90, 192\], *P*\<0.0001), as was median fluoroscopy time (71 minutes \[44, 93\] versus 39 minutes \[25, 69\], *P*\<0.0001), mean air kerma radiation dose (4.98 Gray \[3.11, 6.04\] versus 3.42 Gray \[2.09, 5.09\], *P*\<0.0001), and median contrast volume (310 mL \[240, 400\] versus 270 mL \[200, 360\], *P*=0.004) as compared with cases in which intravascular imaging was not used.

![Technical, procedural success and MACE among study procedures classified according to use of intravascular imaging for crossing. MACE indicates major cardiac adverse event.](JAH3-5-e003890-g004){#jah31711-fig-0004}

Intravascular Imaging for Stent Sizing and/or Optimization {#jah31711-sec-0013}
----------------------------------------------------------

Among CTOs successfully crossed with a guidewire, cases in which imaging was used for stent sizing and optimization were more complex, as reflected by higher Japanese Chronic Total Occlusion (2.65±1.17 versus 2.38±1.22, *P*=0.013) and Progress CTO (1.39±1.09 versus 1.19±0.98, *P*=0.035) scores (Tables [4](#jah31711-tbl-0004){ref-type="table-wrap"} and [5](#jah31711-tbl-0005){ref-type="table-wrap"}). They were also more likely to have moderate/severe calcification (63% versus 47%, *P*=0.001), longer occlusion length (30 mm \[20, 50\] versus 28 mm \[15, 40\], *P*=0.030) or be due to in‐stent restenosis (23% versus 14%, *P*=0.015) and required longer procedure (162 minutes \[113, 216\] versus 133 minutes \[91, 201\], *P*=0.001) and fluoroscopy (52 minutes \[33, 81\] versus 40 minutes \[26, 73\], *P*=0.014) time with a trend for higher air kerma radiation dose (3.90 Gray \[2.48, 5.46\] versus 3.48 Gray \[2.13, 5.34\], *P*=0.249) and contrast volume (300 mL \[228, 368\] versus 277 mL \[200, 370\], *P*=0.106). Use of intravascular imaging was associated with similar technical (97.7% versus 97.5%, *P*=0.854) and procedural (97.1% versus 95.4%, *P*=0.347) success rates and similarly low MACE rates (2.3% versus 3.1%, *P*=0.622) (Figure [5](#jah31711-fig-0005){ref-type="fig"}). There was a trend toward larger number of stents in procedures where intravascular imaging was used for stent sizing/and/or optimization (2.7±1.3 versus 2.5±1.2, *P*=0.07).

###### 

Angiographic Characteristics Classified According to Whether or Not Intravascular Imaging Technique Was Used for Stent Optimization

  Variable                                                      Overall          Imaging for Stent Optimization   No Imaging or Imaging for Crossing Only   *P‐*Value
  ------------------------------------------------------------- ---------------- -------------------------------- ----------------------------------------- -----------
  CTO target vessel                                                                                                                                         0.137
  RCA                                                           51%              49%                              52%                                       
  LAD                                                           27%              32%                              25%                                       
  LCX                                                           22%              19%                              23%                                       
  Successful crossing strategy                                                                                                                              0.001
  Antegrade wiring                                              51%              42%                              55%                                       
  Retrograde                                                    24%              27%                              23%                                       
  Antegrade dissection and re‐entry                             25%              31%                              22%                                       
  First crossing strategy                                                                                                                                   0.321
  Antegrade wiring                                              78%              77%                              79%                                       
  Retrograde                                                    14%              13%                              14%                                       
  Antegrade dissection and re‐entry                             8%               10%                              7%                                        
  Retrograde crossing attempt                                   36%              45%                              32%                                       0.003
  J‐CTO score[a](#jah31711-note-0010){ref-type="fn"}            2.47±1.21        2.65±1.17                        2.38±1.22                                 0.013
  Progress CTO score[a](#jah31711-note-0010){ref-type="fn"}     1.25±1.02        1.39±1.09                        1.19±0.98                                 0.035
  Calcification (moderate/severe)                               52%              63%                              47%                                       0.001
  Tortuosity (moderate/severe)                                  41%              42%                              40%                                       0.742
  Proximal cap ambiguity                                        30%              34%                              28%                                       0.155
  In‐stent restenosis                                           17%              23%                              14%                                       0.015
  Prior failure to open CTO                                     16%              18%                              15%                                       0.429
  Interventional Collaterals                                    53%              52%                              54%                                       0.648
  Side branch at the proximal cap                               49%              50%                              48%                                       0.753
  Blunt/no stump                                                55%              50%                              57%                                       0.123
  Vessel diameter, mm[b](#jah31711-note-0011){ref-type="fn"}    2.5 (2.5, 3.0)   2.8 (2.5, 3)                     2.5 (2.5, 3)                              0.257
  Occlusion length, mm[b](#jah31711-note-0011){ref-type="fn"}   30 (18, 45)      30 (20, 50)                      28 (15, 40)                               0.03
  Number of stents used                                         2.5±1.2          2.7±1.3                          2.5±1.2                                   0.076

Imaging for stent optimization: cases in which intravascular imaging was used for stent optimization. No imaging or imaging for crossing only: cases in which intravascular imaging was not used or cases in which intravascular imaging was used only for crossing the chronic total occlusion. CTO indicates chronic total occlusion; J‐CTO score, Japanese chronic total occlusion score; LAD, left anterior descending artery; LCX, left circumflex artery; P‐CTO score, Progress chronic total occlusion score; RCA, right coronary artery.

Mean±SD.

Median (interquartile range).

###### 

Procedural Outcomes of the Study Patients, Classified According to Whether Intravascular Imaging was Used for Stent Optimization or Not

  Variable                                                                 Overall             Imaging for Stent Optimization   No Imaging or Imaging for Crossing Only   *P‐*Value
  ------------------------------------------------------------------------ ------------------- -------------------------------- ----------------------------------------- -----------
  Technical success                                                        97.5%               97.7%                            97.5%                                     0.854
  Procedural success                                                       95.9%               97.1%                            95.4%                                     0.347
  Procedural time, min[a](#jah31711-note-0013){ref-type="fn"}              143 (97, 205)       162 (113, 216)                   133 (91, 201)                             0.001
  Fluoroscopy time, min[a](#jah31711-note-0013){ref-type="fn"}             44 (27, 75)         52 (33, 81)                      40 (26, 73)                               0.014
  Air kerma radiation dose (Gray)[a](#jah31711-note-0013){ref-type="fn"}   3.60 (2.24, 5.37)   3.90 (2.48, 5.46)                3.48 (2.13, 5.34)                         0.249
  Contrast volume[a](#jah31711-note-0013){ref-type="fn"}                   282 (205, 369)      300 (228, 368)                   277 (200, 370)                            0.106
  MACE                                                                     2.9%                2.3%                             3.1%                                      0.622
  Death                                                                    0.4%                0.0%                             0.5%                                      0.347
  Acute Q wave MI                                                          0%                  0%                               0.0%                                      
  Acute MI                                                                 1.3%                0.6%                             1.6%                                      0.346
  Re‐PCI                                                                   0.4%                0.0%                             0.5%                                      0.347
  Stroke                                                                   0.7%                0.6%                             0.8%                                      0.808
  Emergency CABG                                                           0%                  0%                               0.0%                                      
  Pericardiocentesis                                                       0.7%                1.2%                             0.5%                                      0.398

Imaging for stent optimization: cases in which intravascular imaging was used for stent optimization. No imaging or imaging for crossing only: cases in which intravascular imaging was not used or cases in which intravascular imaging was used only for crossing the chronic total occlusion. CABG, coronary artery bypass graft; MACE, major adverse cardiac events; MI, myocardial infarction; PCI, percutaneous coronary intervention.

Median (interquartile range).

![Technical, procedural success and major cardiac adverse events according to purpose of intravascular imaging techniques. IMG indicates imaging; MACE, major cardiac adverse events.](JAH3-5-e003890-g005){#jah31711-fig-0005}

Discussion {#jah31711-sec-0014}
==========

The main findings of our study are that intravascular imaging is frequently performed during CTO PCI both for crossing and for stent selection/optimization. Intravascular imaging was used in more complex occlusions and was associated with similarly high success rates, but longer procedure time and higher radiation dose.

Frequency of Intravascular Imaging Use in CTO PCI {#jah31711-sec-0015}
-------------------------------------------------

In our study, intravascular imaging was used in 38% of CTO PCI cases, which is similar to 39% utilization in the Multicenter Korean CTO Registry.[1](#jah31711-bib-0001){ref-type="ref"} Okamura et al reported use of IVUS in 47.5% of patients in their study about complications during retrograde approach in the Japanese Multicenter CTO Registry IVUS.[28](#jah31711-bib-0028){ref-type="ref"} In contrast, in the European Registry of Chronic Total Occlusion, IVUS use was significantly lower (2.9% overall[29](#jah31711-bib-0029){ref-type="ref"} and 9.2% in retrograde cases[30](#jah31711-bib-0030){ref-type="ref"}), suggesting that imaging use may be low even among experienced operators and centers. Habara et al[31](#jah31711-bib-0031){ref-type="ref"} compared CTO PCI outcomes according to operator experience: when using the antegrade approach after retrograde failure, the success rate of IVUS‐guided techniques was significantly higher in higher‐volume centers than lower‐volume centers (13.3% versus 3.3%; *P*=0.018). Therefore, IVUS guidance for antegrade crossing requires high operator skill and experience.[32](#jah31711-bib-0032){ref-type="ref"} Moreover, the cost of catheters and the additional time required for obtaining and interpreting the images can affect the use of intravascular imaging and may explain the wide variability in its use for CTO (and non‐CTO) PCI.

Selection of Intravascular Imaging Modality for CTO PCI {#jah31711-sec-0016}
-------------------------------------------------------

IVUS was the intravascular imaging modality used in most CTO PCIs, and in contrast to OCT, does not require flushing of the blood column within the arterial lumen and has higher penetration depth. OCT performed before stenting could also cause subintimal hematoma due to the need for contrast administration for image acquisition. OCT, however, offers superior resolution compared to IVUS and has been used in CTO PCI to determine guidewire position and stent optimization after deployment. The ALSTER OCT‐CTO (AskLepios ST. GEoRg\'s Hospital‐Optical Coherence Tomography for follow‐up of Chronic Total Occlusions) registry reported a significantly higher rate of uncovered and malapposed stent struts in CTOs as compared to nonocclusive lesions.[33](#jah31711-bib-0033){ref-type="ref"} These findings may favor prolonged administration of dual antiplatelet therapy, in an attempt to reduce the risk of stent thrombosis.[34](#jah31711-bib-0034){ref-type="ref"}

Solid‐state, phased‐array catheters (Eagle‐Eye, Volcano) are preferred over rotational IVUS systems, because the imaging transducer is closer to the tip of the IVUS catheter. A short‐tip solid‐state IVUS catheter (Eagle Eye Short Tip, Volcano) is advantageous for imaging in CTO PCI, as it minimizes the extent of distal advancement required for distal imaging and may be more deliverable.[10](#jah31711-bib-0010){ref-type="ref"}

Imaging for CTO Crossing {#jah31711-sec-0017}
------------------------

Intravascular imaging can assist CTO crossing by (1) identifying the proximal cap in cases with proximal cap ambiguity (for example, by imaging through a side branch adjacent to the occlusion)[4](#jah31711-bib-0004){ref-type="ref"}; (2) confirming whether the antegrade guidewire has engaged the occlusion and navigating the antegrade guidewire to the true lumen in case of dissection[5](#jah31711-bib-0005){ref-type="ref"}, [35](#jah31711-bib-0035){ref-type="ref"}; (3) confirming that the retrograde guidewire has entered the proximal true lumen before externalization; and (4) determining the appropriate balloon size for the CART and reverse CART techniques.[10](#jah31711-bib-0010){ref-type="ref"}, [11](#jah31711-bib-0011){ref-type="ref"} Moreover, use of IVUS could assist re‐entry into the distal true lumen after subintimal crossing[35](#jah31711-bib-0035){ref-type="ref"} and reduce the need for fluoroscopy and contrast injection.[5](#jah31711-bib-0005){ref-type="ref"} In our study, 3 characteristics of CTOs were associated with IVUS utilization during crossing: side branch at proximal cap (61% versus 47%, *P*=0.009), proximal cap ambiguity (49% versus 26%, *P*\<0.001), and blunt/no stump (68% versus 55%, 0.009).

Park et al reported that the IVUS‐guided wiring technique was useful and safe for antegrade recanalization of 31 stumpless CTOs (Table [6](#jah31711-tbl-0006){ref-type="table-wrap"}). The IVUS catheter was advanced into the side branch to identify the CTO entry point, while another stiffer guidewire was directed under IVUS guidance to the occlusion entry point and penetrated the proximal cap. In case of subintimal position of the guidewire, IVUS was also used to redirect the wire into the true lumen. However, this technique has 2 potential limitations: first, IVUS cannot provide information on the course of the vessel distal to the occlusion (dual injection can be used to visualize the entire course of the vessel distal to the occlusion); second, IVUS‐guided wiring cannot be applied in cases without appropriate side branches (for example, with smaller vessel diameter than the IVUS catheters).[4](#jah31711-bib-0004){ref-type="ref"}

###### 

Summary of Published Reports of Intravascular Ultrasound Use in CTO PCI

                                                           Author                                              Year   No. of Patients   No. of Lesions   Imaging Frequency                                                                                                                                                                                        Comments
  -------------------------------------------------------- --------------------------------------------------- ------ ----------------- ---------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Intravascular imaging for crossing                                                                                                                                                                                                                                                                                                                              
  Antegrade crossing                                       Park et al[4](#jah31711-bib-0004){ref-type="ref"}   2011   31                32               100%                                                                                                                                                                                                     IVUS‐guided wiring is technically feasible and safe for recanalization of stumpless CTO lesions
  Ito et al[35](#jah31711-bib-0035){ref-type="ref"}        2004                                                2      2                 100%             Case report: (1) IVUS advanced into a side branch to identify the entry point of the major branch (2) IVUS‐guided penetration of the guidewire from the false lumen to the true lumen after dissection   
  Matsubara et al[5](#jah31711-bib-0005){ref-type="ref"}   2004                                                2      2                 100%             Case report: (1) IVUS catheter in the subintima was used to guide the wire into the true lumen. (2) The orifice of the LAD was identified by imaging with IVUS in a diagonal branch                      
  Retrograde crossing                                      Dai et al[11](#jah31711-bib-0011){ref-type="ref"}   2013   49                49               100%                                                                                                                                                                                                     IVUS‐guided reverse CART approach is efficient and safe for revascularization of complex CTOs
  Intravascular imaging for stent optimization                                                                                                                                                                                                                                                                                                                    
  Retrospective studies                                    Kang et al[6](#jah31711-bib-0006){ref-type="ref"}   2015   126               126              100%                                                                                                                                                                                                     Among patients in whom IVUS was used post CTO PCI, post CTO‐PCI angiographic minimum luminal diameter ≤2.4 mm and stent expansion ratio ≤70% as assessed by IVUS were both independent predictors of in‐stent restenosis
  Hong et al[1](#jah31711-bib-0001){ref-type="ref"}        2014                                                534    534               50%              IVUS was used in 39% of CTO PCI and was associated with lower risk for stent thrombosis and a trend for lower incidence of myocardial infarction as compared with angiography‐guided CTO PCI             
  Tsujita et al[32](#jah31711-bib-0032){ref-type="ref"}    2009                                                 48    48                100%             Compared antegrade and retrograde approaches with IVUS after crossing; IVUS can be a useful tool for the detection of procedure‐related vessel damage and subintimal wire tracking                       
  Prospective randomized‐controlled clinical trials        Kim et al[3](#jah31711-bib-0003){ref-type="ref"}    2015   402               402              50%                                                                                                                                                                                                      Randomized‐controlled trial of IVUS guidance in CTO PCI demonstrating lower 12‐month incidence of MACE in the IVUS‐guidance group
  Tian et al[2](#jah31711-bib-0002){ref-type="ref"}        2015                                                230    230               50%              Randomized‐controlled trial of IVUS guidance in CTO PCI demonstrating that IVUS guidance was associated with less late lumen loss and a lower incidence of 12‐month in‐stent restenosis                  

CART indicates controlled antegrade and retrograde tracking and dissection; CTO, chronic total occlusion; IVUS, intravascular ultrasound; LAD, left anterior descending artery; MACE, major adverse cardiac events; PCI, percutaneous coronary intervention.

IVUS may be particularly useful for the retrograde approach to CTO crossing, as retrograde cases are often more complex than antegrade‐only cases due to difficulties crossing the collateral and/or crossing the occlusion and externalizing the guidewire. Indeed, IVUS was used in 67% of retrograde versus 31% of antegrade‐only cases in our study (*P*\<0.0001). IVUS can clarify the location of guidewires and guide balloon size selection when performing reverse CART. Dai et al showed that the IVUS‐guided reverse CART approach is efficient and safe for revascularization of complex CTOs. They overlapped an antegrade and a retrograde guidewire within the occlusion and inflated a small balloon (1.2--1.5 mm) to create an antegrade subintimal or intimal dissection. The IVUS catheter was then advanced into the dissection plane to guide crossing of the occlusion.[11](#jah31711-bib-0011){ref-type="ref"}

Imaging for Stent Optimization {#jah31711-sec-0018}
------------------------------

Intravascular imaging can assist with optimizing stent diameter and length selection, and further ensure that optimal expansion has occurred.[10](#jah31711-bib-0010){ref-type="ref"} Two randomized‐controlled trials have compared IVUS guidance versus angiographic guidance for stent optimization after CTO PCI. Kim et al randomized 402 patients to IVUS guidance versus angiographic guidance and found that IVUS guidance reduced the subsequent incidence of MACE.[3](#jah31711-bib-0003){ref-type="ref"} Similarly, Tian et al in the AIR‐CTO (Angiographic and clinical comparisons of intravascular ultrasound‐ versus angiography‐guided drug‐eluting stent implantation for patients with Chronic Total Occlusion lesions) study randomized 230 patients to IVUS or angiographic guidance and found that IVUS guidance was associated with lower in‐stent late lumen loss at 1‐year angiographic and IVUS follow‐up, leading to less frequent restenosis and lower rates of stent thrombosis.[2](#jah31711-bib-0002){ref-type="ref"} These findings are in agreement with the findings of the IVUS‐XPL (The Impact of Intravascular Ultrasound Guidance on Outcomes of Xience Prime Stents in Long Lesions) study that randomized 1400 patients to undergo IVUS‐guided or angiography‐guided everolimus‐eluting stent implantation in non‐CTO long lesions and resulted in a significantly lower rate of 12‐month MACE, primarily driven by lower risk for target lesion revascularization.[36](#jah31711-bib-0036){ref-type="ref"} Use of intravascular imaging (either IVUS or OCT) can help identify and treat stent underexpansion, which is an important risk factor for both restenosis[6](#jah31711-bib-0006){ref-type="ref"} and stent thrombosis. Use of intravascular imaging may be of particular importance in long and calcified CTOs. In our study we observed a trend toward a higher number of stents in procedures guided by IVUS. This could be related to higher lesion complexity among imaged lesions, but could also indicate increased detection of dissection flaps, gaps between stents, or untreated residual coronary disease that might have not been apparent during diagnostic angiography.

Intravascular Imaging and Contrast Use {#jah31711-sec-0019}
--------------------------------------

Mariani et al in the MOZART (Minimizing cOntrast utilization With IVUS Guidance in CoRonary angioplasTy) trial found that IVUS as a primary imaging tool to guide PCI was safe and markedly reduced the volume of iodine contrast as compared with angiography‐guided PCI.[37](#jah31711-bib-0037){ref-type="ref"} Dai et al suggested that the IVUS‐guided reverse CART technique could reduce the contrast volume.[11](#jah31711-bib-0011){ref-type="ref"} However, in our study contrast volume was higher among cases in which intravascular imaging was used for crossing, likely reflecting the higher complexity of such cases.

Study Limitations {#jah31711-sec-0020}
-----------------

Our study has potential limitations. First, PROGRESS CTO is an observational registry without adjudication of clinical events by an independent event committee. Second, quantitative coronary angiographic analysis was not performed and therefore assessment of angiographic characteristics was subject to operator‐related bias. Third, procedures were performed by experienced operators in CTO PCI, limiting extrapolation of the study results to less experienced centers and operators. Fourth, use of intravascular imaging was performed at the discretion of the operator, with high variability between centers. Fifth, few patients (n=13) had more than 1 CTO PCI.

Conclusion {#jah31711-sec-0021}
----------

In summary, intravascular imaging is frequently performed during CTO PCI both for crossing and for stent selection/optimization. Even though intravascular imaging was used in more complex lesions, it was associated with similar rates of technical and procedural success, but higher use of radiation and longer procedure time.
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Study data were collected and managed using REDCap electronic data capture tools hosted at University of Texas Southwestern Medical Center.[38](#jah31711-bib-0038){ref-type="ref"} REDCap (Research Electronic Data Capture) is a secure, web‐based application designed to support data capture for research studies, providing (1) an intuitive interface for validated data entry; (2) audit trails for tracking data manipulation and export procedures; (3) automated export procedures for seamless data downloads to common statistical packages; and (4) procedures for importing data from external sources.
